The bactericidal effect of lysostaphin coupled with liposomal vancomycin as a dual combating system applied directly on methicillin-resistant Staphylococcus aureus infected skin wounds in mice 

References

• Munita JM, Arias CA. Mechanisms of antibiotic resistance. Microbiol Spectr. 2016;4(2). doi:10.1128/microbiolspec.VMBF-0016-2015.
   PubMed Web of Science ®Google Scholar
• Katakura T, Yoshida T, Kobayashi M, Herndon D, Suzuki F. Immunological control of methicillin‐resistant Staphylococcus aureus (MRSA) infection in an immunodeficient murine model of thermal injuries. J Clin Exp Immunol. 2005;142(3):419–425.
   Web of Science ®Google Scholar
• Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998–2004). Diagn Microbiol Infect Dis. 2007;57(1):7–13. doi:10.1016/j.diagmicrobio.2006.05.00917059876
   PubMed Web of Science ®Google Scholar
• Gurusamy KS, Koti R, Toon CD, Wilson P, Davidson B. Antibiotic therapy for the treatment of methicillin‐resistant Staphylococcus aureus (MRSA) infections in surgical wounds. Cochrane Database Syst Rev. 2013;8:CD009726.
   Web of Science ®Google Scholar
• Mohammad H, Thangamani S, Seleem NM. Antimicrobial peptides and peptidomimetics-potent therapeutic allies for Staphylococcal infections. Curr Pharm Des. 2015;21(16):2073–2088.25760338
   PubMed Web of Science ®Google Scholar
• Stryjewski ME, Chambers HF. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46(Supplement_5):S368–S377. doi:10.1086/53359318462092
   PubMedGoogle Scholar
• NOW MM, COMMON BSAS. Skin and soft-tissue infections: classifying and treating a spectrum. Cleve Clin J Med. 2012;79(1):57. doi:10.3949/ccjm.79a.1104422219235
   PubMedGoogle Scholar
• Boswihi SS, Udo EE. Methicillin-resistant Staphylococcus aureus: an update on the epidemiology, treatment options and infection control. J Curr Med Res Pract. 2018;8(1):18–24. doi:10.1016/j.cmrp.2018.01.001
   Google Scholar
• Wong M, Chapman MG, Malhotra S, Mirzanejad Y, Deans GD. Experience with high dose once-daily vancomycin for patients with skin and soft-tissue infections in an ambulatory setting. Open Forum Infect Dis. 2017;4(Suppl 1):S338.
   Google Scholar
• Bruniera F, Ferreira F, Saviolli L, et al. The use of vancomycin with its therapeutic and adverse effects: a review. Eur Rev Med Pharmacol Sci. 2015;19(4):694–700.25753888
   PubMed Web of Science ®Google Scholar
• Touitou E, Junginger H, Weiner N, Nagai T, Mezei M. Liposomes as carriers for topical and transdermal delivery. J Pharm Pharm. 1994;83(9):1189–1203.
   Google Scholar
• Weiner N, Lieb L, Niemiec S, Ramachandran C, Hu Z, Egbaria K. Liposomes: a novel topical delivery system for pharmaceutical and cosmetic applications. J Drug Target. 1994;2(5):405–410. doi:10.3109/106118694089968167704485
   PubMed Web of Science ®Google Scholar
• Shanmugasundaram N, Uma T, Ramyaa Lakshmi T, Babu M. The Japanese society for biomaterials, biomaterials TASf, biomaterials tKSf. Efficiency of controlled topical delivery of silver sulfadiazine in infected burn wounds. J Biomed Mater Res A. 2009;89(2):472–482. doi:10.1002/jbm.a.3199718431769
   PubMedGoogle Scholar
• Teo EY, Ong S-Y, Chong MSK, et al. Polycaprolactone-based fused deposition modeled mesh for delivery of antibacterial agents to infected wounds. Biomaterials. 2011;32(1):279–287. doi:10.1016/j.biomaterials.2010.08.08920870283
   PubMed Web of Science ®Google Scholar
• Surewaard BG, Deniset JF, Zemp FJ, et al. Identification and treatment of the Staphylococcus aureus reservoir in vivo. J Exp Med. 2016;213(7):1141–1151. 27325887
   PubMed Web of Science ®Google Scholar
• Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiol Rev. 1991;55(4):733–751.1779933
   PubMedGoogle Scholar
• Chen C, Fan H, Huang Y, et al. Recombinant lysostaphin protects mice from methicillin-resistant Staphylococcus aureus pneumonia. Biomed Res Int. 2014;2014:602185.
   PubMed Web of Science ®Google Scholar
• Nithya S, Nimal T, Baranwal G, et al. Preparation, characterization and efficacy of lysostaphin-chitosan gel against Staphylococcus aureus. Int J Biol Macromol. 2018;110:157–166. doi:10.1016/j.ijbiomac.2018.01.08329410001
   PubMed Web of Science ®Google Scholar
• Kateete DP, Kimani CN, Katabazi FA, et al. Identification of Staphylococcus aureus: dNase and mannitol salt agar improve the efficiency of the tube coagulase test. Ann Clin Microbiol Antimicrob. 2010;9(1):23. doi:10.1186/1476-0711-9-2320707914
   PubMedGoogle Scholar
• Clinical Institute LS. Performance Standards for Antimicrobial Susceptibility Testing. Document M100-S15 Wayne, PA: Clinical and Laboratory Standards Institute; 2016.
   Google Scholar
• Heydari N, Alikhani M, Jalilian F, Tahmasebi H, Arabestani M. Evaluation of real time PCR for detection of clinical isolates of Staphylococcus aureus and methicillin-resistance strains based on melting curve analysis method. Koomesh. 2017;19(4):877–886.
   Google Scholar
• Jarraud S, Mougel C, Thioulouse J, et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun. 2002;70(2):631–641. doi:10.1128/iai.70.2.631-641.200211796592
   PubMed Web of Science ®Google Scholar
• Eleaume H, Jabbouri S. Comparison of two standardisation methods in real-time quantitative RT-PCR to follow Staphylococcus aureus genes expression during in vitro growth. J Microbiol Methods. 2004;59(3):363–370. doi:10.1016/j.mimet.2004.07.01515488279
   PubMedGoogle Scholar
• Zhang H. Thin-film hydration followed by extrusion method for liposome preparation In: Liposomes. Springer; 2017:17–22.
   Google Scholar
• Liu J, Wang Z, Li F, Gao J, Wang L, Huang G. Liposomes for systematic delivery of vancomycin hydrochloride to decrease nephrotoxicity: characterization and evaluation. Asian J Pharm Clin Res. 2015;10(3):212–222.
   Google Scholar
• Labella C, Lelario F, Bufo SA, Musto M, Freschi P, Cosentino C. Optimization and validation of a chromatographic method for quantification of lysozyme in jenny milk. Nutr Res. 2016;55(3):263–269.
   Web of Science ®Google Scholar
• Ordóñez-Gutiérrez L, Posado-Fernández A, Ahmadvand D, et al. ImmunoPEGliposome-mediated reduction of blood and brain amyloid levels in a mouse model of Alzheimer’s disease is restricted to aged animals. Biomaterials. 2017;112:141–152. doi:10.1016/j.biomaterials.2016.07.02727760398
   PubMedGoogle Scholar
• Tseng CW, Sanchez-Martinez M, Arruda A, Liu GY. Subcutaneous infection of methicillin resistant Staphylococcus aureus (MRSA). J Vis Exp. 2011;(48). doi:10.3791/2528.
   PubMed Web of Science ®Google Scholar
• Vyas LK, Tapar KK, Nema RK, Parashar AK. Development and characterization of topical liposomal gel formulation for anti-cellulite activity. International Journal of Pharmacy and Pharmaceutical Sciences 2013;5:512–516.
   Google Scholar
• Sande L, Sanchez M, Montes J, et al. Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model. J Antimicrob Chemothe. 2012;67(9):2191–2194. doi:10.1093/jac/dks212
   PubMed Web of Science ®Google Scholar
• Desbois AP, Gemmell CG, Coote PJ. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections. Int J Antimicrob Agents. 2010;35(6):559–565. doi:10.1016/j.ijantimicag.2010.01.01620206480
   PubMedGoogle Scholar
• Yang X-Y, Li C-R, Lou R-H, et al. In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China. J Med Microbiol. 2007;56(1):71–76. doi:10.1099/jmm.0.46788-017172520
   PubMedGoogle Scholar
• Narasimhaswamy N, Bairy I, Manuel A, Mathew J, Shenoy G, Bairy L. In-vitro bactericidal activity of recombinant lysostaphin on biofilm producing methicillin resistant Staphylococcus aureus. Int J Curr Microbiol App Sci. 2015;4(1):822–830.
   Google Scholar
• Cui F, Li G, Huang J, et al. Development of chitosan-collagen hydrogel incorporated with lysostaphin (CCHL) burn dressing with anti-methicillin-resistant Staphylococcus aureus and promotion wound healing properties. J Drug Deliv Sci Technol. 2011;18(3):173–180.
   Google Scholar
• Miao J, Pangule RC, Paskaleva EE, et al. Lysostaphin-functionalized cellulose fibers with antistaphylococcal activity for wound healing applications. Biomaterials. 2011;32(36):9557–9567. doi:10.1016/j.biomaterials.2011.08.08021959009
   PubMed Web of Science ®Google Scholar
• Gründling A, Schneewind O. Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus. J Bacteriol. 2006;188(7):2463–2472. doi:10.1128/JB.188.7.2463-2472.200616547033
   PubMed Web of Science ®Google Scholar
• Pornpattananangkul D, Zhang L, Olson S, et al. Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. J Am Chem Soc. 2011;133(11):4132–4139. doi:10.1021/ja111110e21344925
   PubMed Web of Science ®Google Scholar
• Nguyen HM, Graber CJ. Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer? J Antimicrob Chemother. 2009;65(1):24–36. doi:10.1093/jac/dkp377
   Web of Science ®Google Scholar
• Hasan R, Acharjee M, Noor R. Prevalence of vancomycin resistant Staphylococcus aureus (VRSA) in methicillin resistant S. aureus (MRSA) strains isolated from burn wound infections. Ci Ji Yi Xue Za Zhi. 2016;28(2):49–53. doi:10.1016/j.tcmj.2016.03.00228757721
   PubMedGoogle Scholar
• Loomba PS, Taneja J, Mishra B. Methicillin and vancomycin resistant S. aureus in hospitalized patients. J Infect Dis. 2010;2(3):275.
   Google Scholar
• Kusuma C, Jadanova A, Chanturiya T, Kokai-Kun JF. Lysostaphin-resistant variants of Staphylococcus aureus demonstrate reduced fitness in vitro and in vivo. Antimicrob Agents Chemother. 2007;51(2):475–482. doi:10.1128/AAC.00786-0617101683
   PubMed Web of Science ®Google Scholar
• Stranden AM, Ehlert K, Labischinski H, Berger-Bächi B. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus. J Bacteriol. 1997;179(1):9–16. doi:10.1128/jb.179.1.9-16.19978981974
   PubMed Web of Science ®Google Scholar
• De Jonge B, Sidow T, Chang Y-S, et al. Altered muropeptide composition in Staphylococcus aureus strains with an inactivated femA locus. J Bacteriol. 1993;175(9):2779–2782. doi:10.1128/jb.175.9.2779-2782.19938478340
   PubMedGoogle Scholar